44206-0417-06 6GM globuline, immune carimune 44206-0436-05 5GM globuline, immune privigen 44206-0418-12 12GM globuline, immune carimune 63833-0386-02 thrombin
Ended Awarded
- Contract number
- 36C24820N0225
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $84,601
Award facts
- Contract value 100% obligated
- $84,601.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $84,601.40, was made by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The award is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB).
The contract provides for the delivery of various immune globulin products, including CARIMUNE (6 grams and 12 grams), PRIVIGEN (5 grams), and THROMBIN, which are critical medications used to support healthcare services for veterans. This contract award is not designated as a set-aside, reflecting CSL Behring's status as a large, foreign-owned enterprise. The contract has an ultimate completion date of December 10, 2019 and was awarded on December 5, 2019.
Quick answers
Who was awarded contract 36C24820N0225?
36C24820N0225 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 8 (Veterans Health Administration) on December 5, 2019.
How much is contract 36C24820N0225 worth?
The government has obligated $84,601 on 36C24820N0225.
Is contract 36C24820N0225 an order under another contract?
Yes. 36C24820N0225 is a BPA call under V797D50358-VA24816A0004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24820N0225 competed?
The extent of competition for 36C24820N0225 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award